av/protalix-biotherapeutics--big.svg

COM:PROTALIX

Protalix Biotherapeutics

  • Stock

Last Close

1.69

21/11 21:00

Market Cap

82.11M

Beta: -

Volume Today

529.32K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
6.00M
-
7.31M
21.91%
6.22M
14.98%
5.51M
11.44%
6.54M
18.76%
8.20M
25.42%
8.36M
1.96%
10.62M
26.99%
15.52M
46.14%
17.38M
11.99%
17.92M
3.14%
average payables
5.26M
-
4.60M
12.51%
3.79M
17.65%
3.82M
0.74%
5.76M
50.97%
6.37M
10.44%
5.85M
8.06%
6.86M
17.17%
7.10M
3.58%
6.42M
9.57%
5.09M
20.75%
average receivables
1.75M
-
1.99M
13.54%
1.98M
0.45%
1.38M
30.10%
1.21M
12.73%
3.23M
167.19%
4.71M
46.19%
3.35M
28.94%
2.72M
18.78%
4.01M
47.52%
4.93M
22.80%
book value per share
-0.29
-
-0.60
105.18%
0.11
119.14%
-0.10
185.74%
-2.39
2,330.79%
-3.59
50.55%
-4.74
31.86%
-0.93
80.43%
-0.14
85.26%
-0.22
60.52%
0.41
285.54%
capex per share
-0.02
-
-0.01
58.70%
-0.00
42.16%
-0.01
71.31%
-0.07
784.59%
-0.05
37.06%
-0.04
9.37%
-0.02
46.82%
-0.03
47.09%
-0.01
60.80%
-0.01
7.60%
capex to depreciation
-0.53
-
-0.25
53.19%
-0.20
21.69%
-0.43
118.68%
-0.51
18.12%
-0.41
18.82%
-0.39
5.55%
-0.50
29.74%
-1.31
159.41%
-0.58
55.69%
-0.96
66.83%
capex to operating cash flow
0.06
-
0.03
56.52%
0.02
28.73%
0.03
38.43%
0.10
267.32%
0.09
8.80%
0.03
63.45%
0.03
22.54%
0.14
465.39%
0.03
82.29%
0.87
3,370.44%
capex to revenue
-0.16
-
-0.05
68.46%
-0.11
105.33%
-0.09
13.20%
-0.05
45.32%
-0.02
60.30%
-0.01
42.78%
-0.01
9.16%
-0.04
265.33%
-0.01
65.35%
-0.02
33.08%
cash per share
0.94
-
0.59
36.97%
0.80
36.47%
0.62
22.43%
3.90
525.33%
2.57
34.16%
1.20
53.34%
1.32
10.28%
0.88
33.21%
0.46
48.19%
0.54
18.15%
days of inventory on hand
535.06
-
268.80
49.76%
2.88K
972.73%
227.96
92.09%
187.71
17.66%
336.24
79.12%
273.21
18.75%
439.15
60.74%
400.83
8.73%
313.06
21.90%
302.47
3.38%
days payables outstanding
353.30
-
159.30
54.91%
1.81K
1,039.07%
174.16
90.40%
180.24
3.49%
204.47
13.45%
217.59
6.42%
242.40
11.40%
155.97
35.66%
109.21
29.98%
68.61
37.18%
days sales outstanding
66.29
-
45.36
31.57%
173.38
282.24%
27.50
84.14%
32.65
18.72%
50.41
54.42%
31.37
37.78%
11.61
63.00%
32.76
182.26%
35.14
7.26%
29.38
16.38%
debt to assets
0.59
-
0.98
65.06%
0.80
18.25%
0.94
18.07%
0.72
23.32%
0.78
8.57%
1.34
71.06%
0.95
29.37%
0.45
52.07%
0.60
32.06%
0.31
48.13%
debt to equity
-2.49
-
-1.38
44.61%
7.14
618.08%
-7.79
209.04%
-1.67
78.58%
-0.91
45.61%
-0.87
4.49%
-2.38
174.93%
-5.55
132.80%
-3.15
43.26%
0.78
124.88%
dividend yield
earnings yield
-0.01
-
-0.02
126.51%
0.06
442.17%
-0.07
208.58%
-0.98
1,411.66%
-0.58
41.23%
-0.54
6.74%
-0.14
73.90%
-0.93
557.73%
-0.22
75.72%
0.06
125.20%
enterprise value
3.57B
-
1.72B
51.82%
963.93M
44.02%
465.41M
51.72%
87.70M
81.16%
55.92M
36.24%
91.80M
64.18%
151.94M
65.51%
31.20M
79.47%
82.77M
165.32%
149.36M
80.45%
enterprise value over ebitda
-151.58
-
-68.85
54.58%
-40.94
40.55%
-15.21
62.84%
-2.42
84.06%
-2.98
22.84%
-10.56
254.53%
48.27
557.05%
-1.56
103.22%
-7.68
393.65%
12.82
266.99%
ev to operating cash flow
-116.59
-
-58.81
49.56%
-39.69
32.50%
-14.50
63.47%
-8.78
39.48%
-7.22
17.69%
-4.74
34.34%
-5.82
22.73%
-3.03
47.89%
-3.31
9.15%
-113.32
3,322.88%
ev to sales
310.41
-
113.58
63.41%
220.88
94.47%
50.59
77.09%
4.56
90.99%
1.63
64.17%
1.68
2.78%
2.42
43.92%
0.81
66.33%
1.74
113.59%
2.28
31.26%
free cash flow per share
-0.35
-
-0.32
8.13%
-0.26
19.45%
-0.32
24.64%
-0.84
157.41%
-0.57
31.52%
-1.35
135.13%
-0.92
31.83%
-0.27
71.02%
-0.53
98.72%
-0.03
94.34%
free cash flow yield
-0.01
-
-0.02
94.22%
-0.03
45.31%
-0.07
185.69%
-0.13
73.24%
-0.18
45.59%
-0.41
122.95%
-0.25
38.41%
-0.32
26.48%
-0.39
20.64%
-0.02
95.64%
graham net net
-0.52
-
-0.80
53.38%
-0.06
92.69%
-0.25
333.51%
-3.60
1,314.14%
-4.65
29.23%
-6.09
30.99%
-1.66
72.73%
-0.66
60.21%
-0.67
1.21%
0.09
113.01%
graham number
1.41
-
2.08
48.27%
1.26
39.75%
0.80
36.27%
18.69
2,236.61%
12.06
35.49%
13.73
13.88%
3.27
76.22%
1.54
52.87%
1.23
19.87%
0.96
22.05%
income quality
1.10
-
0.98
11.34%
0.89
8.98%
1.10
23.60%
0.12
89.35%
0.29
149.69%
1.06
261.97%
4.00
277.84%
0.37
90.68%
1.67
349.15%
-0.16
109.47%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
0
0
interest coverage
40.23
-
-5.11
112.69%
-6.34
24.09%
-3.11
50.93%
-3.74
20.21%
-2.51
32.79%
-1.35
46.45%
0.19
114.19%
-2.72
1,525.32%
-5.15
89.14%
3.29
163.92%
interest debt per share
0.72
-
0.88
22.19%
0.86
2.37%
0.87
1.46%
4.72
443.05%
3.78
19.92%
4.64
22.75%
2.54
45.27%
0.93
63.46%
0.74
20.02%
0.36
51.88%
inventory turnover
0.68
-
1.36
99.05%
0.13
90.68%
1.60
1,164.90%
1.94
21.44%
1.09
44.17%
1.34
23.07%
0.83
37.79%
0.91
9.56%
1.17
28.04%
1.21
3.50%
invested capital
-2.49
-
-1.38
44.61%
7.14
618.08%
-7.79
209.04%
-1.67
78.58%
-0.91
45.61%
-0.87
4.49%
-2.38
174.93%
-5.55
132.80%
-3.15
43.26%
0.78
124.88%
market cap
3.59B
-
1.71B
52.43%
968.21M
43.35%
451.18M
53.40%
86.67M
80.79%
45.76M
47.21%
48.67M
6.36%
105.81M
117.40%
36.71M
65.30%
66.41M
80.89%
146.71M
120.93%
net current asset value
-42.38M
-
-68.55M
61.77%
-499K
99.27%
-20.34M
3,975.55%
-40.86M
100.89%
-61.03M
49.38%
-83.23M
36.39%
-39.25M
52.85%
-18.04M
54.05%
-21.55M
19.47%
19.07M
188.49%
net debt to ebitda
0.82
-
-0.51
161.86%
0.18
135.78%
-0.47
356.19%
-0.03
93.91%
-0.54
1,809.25%
-4.96
816.94%
14.66
395.36%
0.27
98.12%
-1.52
652.04%
0.23
114.97%
net income per share
-0.30
-
-0.32
7.14%
0.61
289.68%
-0.29
147.37%
-6.51
2,146.08%
-1.80
72.36%
-1.77
1.65%
-0.51
71.11%
-0.77
50.70%
-0.31
60.00%
0.10
132.75%
operating cash flow per share
-0.33
-
-0.32
5.01%
-0.26
18.84%
-0.32
23.75%
-0.76
140.82%
-0.53
30.98%
-1.30
147.94%
-0.90
31.35%
-0.23
73.98%
-0.52
121.35%
-0.02
96.90%
payables turnover
1.03
-
2.29
121.79%
0.20
91.22%
2.10
941.89%
2.03
3.37%
1.79
11.85%
1.68
6.03%
1.51
10.24%
2.34
55.42%
3.34
42.81%
5.32
59.17%
receivables turnover
5.51
-
8.05
46.14%
2.11
73.84%
13.27
530.55%
11.18
15.77%
7.24
35.24%
11.64
60.72%
31.45
170.25%
11.14
64.57%
10.39
6.77%
12.42
19.59%
research and ddevelopement to revenue
2.16
-
1.43
33.75%
4.59
221.31%
2.68
41.70%
1.50
43.98%
0.97
35.04%
0.82
16.20%
0.61
25.61%
0.78
27.77%
0.62
20.54%
0.26
57.64%
return on tangible assets
-0.25
-
-0.38
55.62%
0.60
256.39%
-0.36
159.83%
-1.18
230.75%
-0.43
63.35%
-0.58
33.58%
-0.22
62.08%
-0.46
110.46%
-0.27
42.00%
0.10
136.79%
revenue per share
0.12
-
0.16
30.93%
0.05
71.83%
0.09
97.35%
1.47
1,517.85%
2.33
58.53%
3.69
58.39%
2.16
41.46%
0.87
59.74%
0.98
13.12%
0.79
19.15%
roe
1.03
-
0.54
47.78%
5.34
891.16%
2.95
44.75%
2.73
7.60%
0.50
81.64%
0.37
25.41%
0.55
47.60%
5.63
922.22%
1.40
75.08%
0.25
82.35%
roic
-0.68
-
-1.08
59.86%
0.59
154.67%
-0.67
213.96%
-1.90
181.97%
4.01
311.05%
4.13
2.93%
0.10
97.64%
-0.76
883.65%
-0.48
37.16%
0.16
132.81%
sales general and administrative to revenue
0.73
-
0.06
-
-0.11
292.75%
-0.08
25.85%
-0.10
29.58%
-0.29
171.97%
-0.39
36.35%
shareholders equity per share
-0.29
-
-0.60
105.18%
0.11
119.14%
-0.10
185.74%
-2.39
2,330.79%
-3.59
50.55%
-4.74
31.86%
-0.93
80.43%
-0.14
85.26%
-0.22
60.52%
0.41
285.54%
stock based compensation to revenue
0.36
-
0.08
76.93%
0.41
404.02%
0.11
73.99%
0.02
83.69%
0.02
14.29%
0.02
1.70%
0.05
225.53%
0.06
24.61%
0.04
29.33%
0.05
20.29%
tangible asset value
-26.95M
-
-55.60M
106.34%
10.87M
119.56%
-9.96M
191.58%
-31.29M
214.28%
-52.88M
68.99%
-70.32M
32.98%
-27.04M
61.55%
-6.04M
77.68%
-10.64M
76.28%
33.57M
415.50%
tangible book value per share
-0.29
-
-0.60
105.18%
0.11
119.14%
-0.10
185.74%
-2.39
2,330.79%
-3.59
50.55%
-4.74
31.86%
-0.93
80.43%
-0.14
85.26%
-0.22
60.52%
0.41
285.54%
working capital
71.21M
-
39.31M
44.79%
74.65M
89.89%
5.66M
92.42%
39.90M
605.55%
27.63M
30.75%
-7.70M
127.85%
-30.75M
299.57%
28.49M
192.65%
12.45M
56.30%
24.40M
95.98%

All numbers in (except ratios and percentages)